Literature DB >> 31685458

What's Old Is New Again: Bacteriophage Therapy in the 21st Century.

Saima Aslam1, Robert T Schooley2.   

Abstract

We highlight features associated with bacteriophage therapy that make it an attractive treatment option for multidrug-resistant infections and also discuss some of the challenges that need to be considered in the design and execution of clinical trials directed at evaluating the efficacy of bacteriophage therapy in humans.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  antimicrobial resistance (AMR); bacteriophage therapy; multidrug resistance (MDR); phage therapy

Mesh：

Substances：

Year:  2019        PMID： 31685458      PMCID： PMC7187564          DOI： 10.1128/AAC.01987-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  A Dutch Case Report of Successful Treatment of Chronic Relapsing Urinary Tract Infection with Bacteriophages in a Renal Transplant Patient.

Authors:  Saskia Kuipers; Mike M Ruth; Mike Mientjes; Ruud G L de Sévaux; Jakko van Ingen
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

2.  Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient.

Authors:  Nancy Law; Cathy Logan; Gordon Yung; Carrie-Lynn Langlais Furr; Susan M Lehman; Sandra Morales; Francisco Rosas; Alexander Gaidamaka; Igor Bilinsky; Paul Grint; Robert T Schooley; Saima Aslam
Journal:  Infection       Date:  2019-05-17       Impact factor: 3.553

3.  Novel bacteriophage therapy for treatment of left ventricular assist device infection.

Authors:  Saima Aslam; Victor Pretorius; Susan M Lehman; Sandra Morales; Robert T Schooley
Journal:  J Heart Lung Transplant       Date:  2019-01-07       Impact factor: 10.247

4.  Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection.

Authors:  Robert T Schooley; Biswajit Biswas; Jason J Gill; Adriana Hernandez-Morales; Jacob Lancaster; Lauren Lessor; Jeremy J Barr; Sharon L Reed; Forest Rohwer; Sean Benler; Anca M Segall; Randy Taplitz; Davey M Smith; Kim Kerr; Monika Kumaraswamy; Victor Nizet; Leo Lin; Melanie D McCauley; Steffanie A Strathdee; Constance A Benson; Robert K Pope; Brian M Leroux; Andrew C Picel; Alfred J Mateczun; Katherine E Cilwa; James M Regeimbal; Luis A Estrella; David M Wolfe; Matthew S Henry; Javier Quinones; Scott Salka; Kimberly A Bishop-Lilly; Ry Young; Theron Hamilton
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

5.  Successful Treatment of Antibiotic-resistant, Poly-microbial Bone Infection With Bacteriophages and Antibiotics Combination.

Authors:  Ran Nir-Paz; Daniel Gelman; Ayman Khouri; Brittany M Sisson; Joseph Fackler; Sivan Alkalay-Oren; Leron Khalifa; Amit Rimon; Ortal Yerushalmy; Reem Bader; Sharon Amit; Shunit Coppenhagen-Glazer; Matthew Henry; Javier Quinones; Francisco Malagon; Biswajit Biswas; Allon E Moses; Greg Merril; Robert T Schooley; Michael J Brownstein; Yoram A Weil; Ronen Hazan
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

6.  Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.

Authors:  Patrick Jault; Thomas Leclerc; Serge Jennes; Jean Paul Pirnay; Yok-Ai Que; Gregory Resch; Anne Françoise Rousseau; François Ravat; Hervé Carsin; Ronan Le Floch; Jean Vivien Schaal; Charles Soler; Cindy Fevre; Isabelle Arnaud; Laurent Bretaudeau; Jérôme Gabard
Journal:  Lancet Infect Dis       Date:  2018-10-03       Impact factor: 25.071

7.  Bacteriophages as Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Tamta Tkhilaishvili; Tobias Winkler; Michael Müller; Carsten Perka; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

8.  Salvage Debridement, Antibiotics and Implant Retention ("DAIR") With Local Injection of a Selected Cocktail of Bacteriophages: Is It an Option for an Elderly Patient With Relapsing Staphylococcus aureus Prosthetic-Joint Infection?

Authors:  Tristan Ferry; Gilles Leboucher; Cindy Fevre; Yannick Herry; Anne Conrad; Jérôme Josse; Cécile Batailler; Christian Chidiac; Mathieu Medina; S Lustig; Frédéric Laurent
Journal:  Open Forum Infect Dis       Date:  2018-10-24       Impact factor: 3.835

9.  Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus.

Authors:  Rebekah M Dedrick; Carlos A Guerrero-Bustamante; Rebecca A Garlena; Daniel A Russell; Katrina Ford; Kathryn Harris; Kimberly C Gilmour; James Soothill; Deborah Jacobs-Sera; Robert T Schooley; Graham F Hatfull; Helen Spencer
Journal:  Nat Med       Date:  2019-05-08       Impact factor: 53.440

Review 10.  Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy.

Authors:  Frank Oechslin
Journal:  Viruses       Date:  2018-06-30       Impact factor: 5.048
View more
  3 in total

1.  Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States.

Authors:  Saima Aslam; Elizabeth Lampley; Darcy Wooten; Maile Karris; Constance Benson; Steffanie Strathdee; Robert T Schooley
Journal:  Open Forum Infect Dis       Date:  2020-08-27       Impact factor: 3.835

Review 2.  Phage therapeutics: from promises to practices and prospectives.

Authors:  Kanika Bhargava; Gopal Nath; Amit Bhargava; G K Aseri; Neelam Jain
Journal:  Appl Microbiol Biotechnol       Date:  2021-11-25       Impact factor: 4.813

3.  Bacteriophage Cocktails Protect Dairy Cows Against Mastitis Caused By Drug Resistant Escherichia coli Infection.

Authors:  Mengting Guo; Ya Gao; Yibing Xue; Yuanping Liu; Xiaoyan Zeng; Yuqiang Cheng; Jingjiao Ma; Hengan Wang; Jianhe Sun; Zhaofei Wang; Yaxian Yan
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.